Honz Pharmaceutical Co., Ltd. (300086.SZ)
CNY 4.65
(1.31%)
CNY 4.65
(1.31%)
| Year | Operating Income | Operating Income Growth |
|---|---|---|
| 2023 | 24.98 Million CNY | 111.71% |
| 2022 | -213.4 Million CNY | -1097.82% |
| 2021 | 21.38 Million CNY | -63.14% |
| 2020 | 58.02 Million CNY | 403.91% |
| 2019 | -19.09 Million CNY | -155.97% |
| 2018 | 34.11 Million CNY | -48.62% |
| 2017 | 66.38 Million CNY | 37.79% |
| 2016 | 48.17 Million CNY | -40.86% |
| 2015 | 81.46 Million CNY | 17.75% |
| 2014 | 69.18 Million CNY | 176.89% |
| 2013 | 24.98 Million CNY | 120.85% |
| 2012 | 11.31 Million CNY | 335.1% |
| 2011 | -4.81 Million CNY | -103.0% |
| 2010 | 160.43 Million CNY | 40.39% |
| 2009 | 114.27 Million CNY | 97.15% |
| 2008 | 57.96 Million CNY | 56.43% |
| 2007 | 37.05 Million CNY | 0.0% |
| Year | Operating Income | Operating Income Growth |
|---|---|---|
| 2024 Q2 | -70.34 Million CNY | -47.67% |
| 2024 Q1 | -47.63 Million CNY | -221.48% |
| 2024 Q3 | -23.89 Million CNY | 66.03% |
| 2023 Q2 | -120.46 Thousand CNY | -100.67% |
| 2023 Q1 | 17.99 Million CNY | 117.94% |
| 2023 Q4 | 39.21 Million CNY | 222.14% |
| 2023 Q3 | -32.1 Million CNY | -26552.98% |
| 2023 FY | 24.98 Million CNY | 111.71% |
| 2022 Q1 | -48.93 Million CNY | -191.67% |
| 2022 FY | -213.4 Million CNY | -1097.82% |
| 2022 Q4 | -100.33 Million CNY | -310.5% |
| 2022 Q3 | -24.44 Million CNY | 38.43% |
| 2022 Q2 | -39.69 Million CNY | 18.88% |
| 2021 Q4 | 53.38 Million CNY | 211.9% |
| 2021 Q3 | 17.11 Million CNY | 183.28% |
| 2021 Q1 | -28.56 Million CNY | -173.02% |
| 2021 Q2 | -20.55 Million CNY | 28.04% |
| 2021 FY | 21.38 Million CNY | -63.14% |
| 2020 FY | 58.02 Million CNY | 403.91% |
| 2020 Q2 | 27.3 Million CNY | 302.62% |
| 2020 Q3 | 5.07 Million CNY | -81.4% |
| 2020 Q4 | 39.11 Million CNY | 670.2% |
| 2020 Q1 | -13.47 Million CNY | 62.1% |
| 2019 Q2 | -22.41 Million CNY | -158.73% |
| 2019 FY | -19.09 Million CNY | -155.97% |
| 2019 Q1 | 38.16 Million CNY | 235.44% |
| 2019 Q4 | -35.55 Million CNY | -5063.26% |
| 2019 Q3 | 716.43 Thousand CNY | 103.2% |
| 2018 Q1 | 26.16 Million CNY | 78.33% |
| 2018 Q3 | 16.25 Million CNY | -18.18% |
| 2018 FY | 34.11 Million CNY | -48.62% |
| 2018 Q4 | -28.17 Million CNY | -273.36% |
| 2018 Q2 | 19.86 Million CNY | -24.08% |
| 2017 Q4 | 14.67 Million CNY | 16.32% |
| 2017 FY | 66.38 Million CNY | 37.79% |
| 2017 Q1 | 18.07 Million CNY | 133.56% |
| 2017 Q2 | 21.02 Million CNY | 16.31% |
| 2017 Q3 | 12.61 Million CNY | -39.98% |
| 2016 Q3 | 9.34 Million CNY | 23.42% |
| 2016 Q4 | 7.73 Million CNY | -17.19% |
| 2016 Q1 | 23.52 Million CNY | -42.99% |
| 2016 FY | 48.17 Million CNY | -40.86% |
| 2016 Q2 | 7.57 Million CNY | -67.81% |
| 2015 Q2 | 32.72 Million CNY | 485.29% |
| 2015 Q4 | 41.26 Million CNY | 158.44% |
| 2015 Q3 | 15.96 Million CNY | -51.21% |
| 2015 FY | 81.46 Million CNY | 17.75% |
| 2015 Q1 | -8.49 Million CNY | -137.85% |
| 2014 Q4 | 22.44 Million CNY | 16.65% |
| 2014 Q3 | 19.24 Million CNY | 35.33% |
| 2014 Q2 | 14.21 Million CNY | 7.06% |
| 2014 Q1 | 13.27 Million CNY | 620.7% |
| 2014 FY | 69.18 Million CNY | 176.89% |
| 2013 Q2 | 15.82 Million CNY | 194.61% |
| 2013 FY | 24.98 Million CNY | 120.85% |
| 2013 Q4 | -2.55 Million CNY | -140.24% |
| 2013 Q3 | 6.33 Million CNY | -59.95% |
| 2013 Q1 | 5.37 Million CNY | 259.35% |
| 2012 Q4 | -3.37 Million CNY | -135.34% |
| 2012 Q2 | 1.87 Million CNY | -42.64% |
| 2012 Q3 | 9.53 Million CNY | 408.49% |
| 2012 Q1 | 3.27 Million CNY | 135.65% |
| 2012 FY | 11.31 Million CNY | 335.1% |
| 2011 Q3 | -9.84 Million CNY | -1356.09% |
| 2011 Q4 | -9.17 Million CNY | 6.83% |
| 2011 FY | -4.81 Million CNY | -103.0% |
| 2011 Q1 | 13.42 Million CNY | -73.42% |
| 2011 Q2 | 783.8 Thousand CNY | -94.16% |
| 2010 Q3 | 47.13 Million CNY | 41.01% |
| 2010 Q2 | 33.42 Million CNY | 13.77% |
| 2010 FY | 160.43 Million CNY | 40.39% |
| 2010 Q1 | 29.38 Million CNY | -6.23% |
| 2010 Q4 | 50.49 Million CNY | 7.13% |
| 2009 Q2 | 21.99 Million CNY | 41.71% |
| 2009 FY | 114.27 Million CNY | 97.15% |
| 2009 Q1 | 15.52 Million CNY | 0.0% |
| 2009 Q4 | 31.33 Million CNY | -31.02% |
| 2009 Q3 | 45.42 Million CNY | 106.51% |
| 2008 FY | 57.96 Million CNY | 56.43% |
| 2007 FY | 37.05 Million CNY | 0.0% |